149 related articles for article (PubMed ID: 36416845)
1. Proton Pump Inhibitor Therapy in Pediatric Eosinophilic Esophagitis: Predictive Factors and Long-Term Step-Down Efficacy.
Gutiérrez-Junquera C; Fernández-Fernández S; Domínguez-Ortega G; Vila Miravet V; García-Puig R; La Orden-Izquierdo E; Peña Quintana L; Barrio Torres J; Medina Benítez E; Leis R; García-Romero R; Fernández de Valderrama A; Vecino López R; Donado Palencia P;
J Pediatr Gastroenterol Nutr; 2023 Feb; 76(2):191-198. PubMed ID: 36416845
[TBL] [Abstract][Full Text] [Related]
2. Long-term Treatment With Proton Pump Inhibitors Is Effective in Children With Eosinophilic Esophagitis.
Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Borrell B; Román E
J Pediatr Gastroenterol Nutr; 2018 Aug; 67(2):210-216. PubMed ID: 29509636
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry.
Laserna-Mendieta EJ; Casabona S; Guagnozzi D; Savarino E; Perelló A; Guardiola-Arévalo A; Barrio J; Pérez-Martínez I; Lund Krarup A; Alcedo J; de la Riva S; Rey-Iborra E; Santander C; Arias Á; Lucendo AJ;
Aliment Pharmacol Ther; 2020 Sep; 52(5):798-807. PubMed ID: 32677040
[TBL] [Abstract][Full Text] [Related]
4. STAT6 Variants Associate With Relapse of Eosinophilic Esophagitis in Patients Receiving Long-term Proton Pump Inhibitor Therapy.
Mougey EB; Nguyen V; Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Borrell B; Román E; González-Lois C; Chao M; Al-Atrash H; Franciosi JP
Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2046-2053.e2. PubMed ID: 32798708
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor therapy reverses endoscopic features of fibrosis in eosinophilic esophagitis.
Navarro P; Laserna-Mendieta EJ; Guagnozzi D; Casabona S; Perelló A; Savarino E; de la Riva S; Olalla JM; Ghisa M; Serrano-Moya N; Alcolea-Valero C; Ortega-Rabbione G; Majano P; Santander C; Arias Á; Lucendo AJ;
Dig Liver Dis; 2021 Nov; 53(11):1479-1485. PubMed ID: 34120859
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of step-down therapy in adult patients with proton pump inhibitor-responsive oesophageal eosinophilia.
Gómez-Torrijos E; García-Rodríguez R; Castro-Jiménez A; Rodríguez-Sanchez J; Méndez Díaz Y; Molina-Infante J
Aliment Pharmacol Ther; 2016 Feb; 43(4):534-40. PubMed ID: 26662868
[TBL] [Abstract][Full Text] [Related]
7. Optimal Biopsy Protocol to Evaluate Histological Effectiveness of Proton Pump Inhibitor Therapy in Patients with Eosinophilic Esophagitis.
Fujiwara Y; Hashimoto A; Uemura R; Sawada A; Otani K; Tanaka F; Yamagami H; Tanigawa T; Watanabe T; Kabata D; Kuwae Y; Shintani A; Ohsawa M
Digestion; 2019; 100(1):64-71. PubMed ID: 30408792
[TBL] [Abstract][Full Text] [Related]
8. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice.
Laserna-Mendieta EJ; Casabona S; Savarino E; Perelló A; Pérez-Martínez I; Guagnozzi D; Barrio J; Guardiola A; Asensio T; de la Riva S; Ruiz-Ponce M; Rodríguez-Oballe JA; Santander C; Arias Á; Lucendo AJ;
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):2903-2911.e4. PubMed ID: 31988045
[TBL] [Abstract][Full Text] [Related]
10. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis.
Molina-Infante J; Katzka DA; Gisbert JP
Aliment Pharmacol Ther; 2013 Jun; 37(12):1157-64. PubMed ID: 23656497
[TBL] [Abstract][Full Text] [Related]
11. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia.
Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Quevedo S; Bracamonte T; Román E
J Pediatr Gastroenterol Nutr; 2016 May; 62(5):704-10. PubMed ID: 26513622
[TBL] [Abstract][Full Text] [Related]
12. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry.
Navarro P; Feo-Ortega S; Casabona-Francés S; Gutiérrez-Junquera C; Savarino EV; Amorena E; Fernández-Fernández S; Pérez-Martínez I; Oliva S; Barrio J; Masiques-Mas ML; Guardiola-Arévalo A; Guagnozzi D; Racca F; Betoré E; Votto M; Rodríguez-Sánchez A; Barrio ML; Blas-Jhon L; Sánchez-Vegazo CT; García-Morales N; Krarup AL; Dainese R; Martín-Dominguez V; García-Díaz A; Maniero D; Santander C; Arias Á; Laserna-Mendieta EJ; Lucendo AJ
Eur J Pediatr; 2024 May; ():. PubMed ID: 38819501
[TBL] [Abstract][Full Text] [Related]
13. Vonoprazan shows efficacy similar to that of proton pump inhibitors with respect to symptomatic, endoscopic, and histological responses in patients with eosinophilic esophagitis.
Kuzumoto T; Tanaka F; Sawada A; Nadatani Y; Otani K; Hosomi S; Kamata N; Taira K; Nagami Y; Tanigawa T; Watanabe T; Fujiwara Y
Esophagus; 2021 Apr; 18(2):372-379. PubMed ID: 32960382
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic and histological characteristics in patients with eosinophilic esophagitis responsive and non-responsive to proton pump inhibitors.
Vieira GG; Ribeiro LBM; Truppel SK; Rosário Filho NA; Vieira MC
J Pediatr (Rio J); 2020; 96(5):638-643. PubMed ID: 31361987
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of PPI treatment and guideline adherence in 236 patients with eosinophilic oesophagitis-Results from the population-based DanEoE cohort shows a low complication rate.
Frandsen LT; Westmark S; Melgaard D; Krarup AL
United European Gastroenterol J; 2021 Oct; 9(8):910-918. PubMed ID: 34477326
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors in eosinophilic esophagitis (EoE) related to oral immunotherapy: is it as effective as in other EoE?
Shalem T; Cohen DL; Epstein-Rigbi N; Elizur A; Eindor-Abarbanel A; Broide E; Richter V
Eur J Pediatr; 2023 Dec; 182(12):5409-5416. PubMed ID: 37750913
[TBL] [Abstract][Full Text] [Related]
17. Transient PPI responsive esophageal eosinophilia may be a clinical sub-phenotype of pediatric eosinophilic esophagitis.
Dohil R; Newbury RO; Aceves S
Dig Dis Sci; 2012 May; 57(5):1413-9. PubMed ID: 22134787
[TBL] [Abstract][Full Text] [Related]
18. Clinical, histopathological features and efficacy of elimination diet and proton-pump inhibitor therapy in achieving histological remission in Asian children with eosinophilic gastritis.
Ng LQ; Loh W; Ong JX; Merchant K; Chiou FK
J Paediatr Child Health; 2022 Jul; 58(7):1244-1250. PubMed ID: 35388934
[TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a Second PPI Course After Steroid-Induced Remission in Eosinophilic Esophagitis Refractory to Initial PPI Therapy.
Visaggi P; Baiano Svizzero F; Del Corso G; Bellini M; Savarino E; de Bortoli N
Am J Gastroenterol; 2022 Oct; 117(10):1702-1705. PubMed ID: 36087067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
